Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Kala Pharmaceuticals stock | $5.65

Learn how to easily invest in Kala Pharmaceuticals stock.

Kala Pharmaceuticals, Inc is a biotechnology business based in the US. Kala Pharmaceuticals shares (KALA) are listed on the NASDAQ and all prices are listed in US Dollars. Kala Pharmaceuticals employs 188 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Kala Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KALA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Kala Pharmaceuticals stock price (NASDAQ: KALA)

Use our graph to track the performance of KALA stocks over time.

Kala Pharmaceuticals shares at a glance

Information last updated 2021-07-28.
Latest market close$5.65
52-week range$3.40 - $9.97
50-day moving average $5.05
200-day moving average $6.67
Wall St. target price$20.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.87

Buy Kala Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kala Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kala Pharmaceuticals price performance over time

Historical closes compared with the close of $5.65 from 2021-05-28

1 week (2021-07-20) N/A
1 month (2021-07-01) 4.05%
3 months (2021-04-30) -26.91%
6 months (2021-01-27) N/A
1 year (2020-07-27) N/A
2 years (2019-07-27) N/A
3 years (2018-07-27) N/A
5 years (2016-07-27) N/A

Kala Pharmaceuticals financials

Revenue TTM $8.6 million
Gross profit TTM $4.2 million
Return on assets TTM -26.47%
Return on equity TTM -89.76%
Profit margin 0%
Book value $1.72
Market capitalisation $234 million

TTM: trailing 12 months

Shorting Kala Pharmaceuticals shares

There are currently 8.5 million Kala Pharmaceuticals shares held short by investors – that's known as Kala Pharmaceuticals's "short interest". This figure is 0.9% down from 8.5 million last month.

There are a few different ways that this level of interest in shorting Kala Pharmaceuticals shares can be evaluated.

Kala Pharmaceuticals's "short interest ratio" (SIR)

Kala Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Kala Pharmaceuticals shares currently shorted divided by the average quantity of Kala Pharmaceuticals shares traded daily (recently around 2.1 million). Kala Pharmaceuticals's SIR currently stands at 3.95. In other words for every 100,000 Kala Pharmaceuticals shares traded daily on the market, roughly 3950 shares are currently held short.

However Kala Pharmaceuticals's short interest can also be evaluated against the total number of Kala Pharmaceuticals shares, or, against the total number of tradable Kala Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kala Pharmaceuticals's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Kala Pharmaceuticals shares in existence, roughly 130 shares are currently held short) or 0.2021% of the tradable shares (for every 100,000 tradable Kala Pharmaceuticals shares, roughly 202 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Kala Pharmaceuticals.

Find out more about how you can short Kala Pharmaceuticals stock.

Kala Pharmaceuticals share dividends

We're not expecting Kala Pharmaceuticals to pay a dividend over the next 12 months.

Kala Pharmaceuticals share price volatility

Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $3.4 up to $9.969. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kala Pharmaceuticals's is 0.4288. This would suggest that Kala Pharmaceuticals's shares are less volatile than average (for this exchange).

Kala Pharmaceuticals overview

Kala Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company's product candidates include EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development programs comprise KPI-285/KPI-286, a receptor tyrosine kinase inhibitor program for the treatment of various retinal diseases; SEGRM program, a novel class of compounds designed to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway; and surface targeted steroid program (KPI-333), a new chemical entity as a topical steroid that targets the ocular surface. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009.

Kala Pharmaceuticals in the news

There are no recent company news

Frequently asked questions

What percentage of Kala Pharmaceuticals is owned by insiders or institutions?
Currently 0.324% of Kala Pharmaceuticals shares are held by insiders and 67.277% by institutions.
How many people work for Kala Pharmaceuticals?
Latest data suggests 188 work at Kala Pharmaceuticals.
When does the fiscal year end for Kala Pharmaceuticals?
Kala Pharmaceuticals's fiscal year ends in December.
Where is Kala Pharmaceuticals based?
Kala Pharmaceuticals's address is: 490 Arsenal Way, Watertown, MA, United States, 02472
What is Kala Pharmaceuticals's ISIN number?
Kala Pharmaceuticals's international securities identification number is: US4831191030
What is Kala Pharmaceuticals's CUSIP number?
Kala Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 483119103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site